Nuplazid 34 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FQAJQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,459
Award facts
- Contract value 100% obligated
- $3,458.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc. for the supply of Nuplazid 34 mg capsules (30-count units), with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued on September 15, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this work at its primary facility in Park Ridge. The award represents a continuation of the company's established role as a key supplier within the federal pharmaceutical supply chain, fulfilling the Defense Logistics Agency's medical supply requirements for military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products. The IDC encompasses branded and generic prescription drugs, over-the-counter medications, biologics, and specialty medications across multiple product categories, supporting the pharmaceutical supply needs of Department of Defense healthcare sites nationwide. DMS Pharmaceutical Group's consistent success in securing federal pharmaceutical contracts without set-aside designations demonstrates its competitive positioning and capability to serve as a reliable distributor of critical medications to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FQAJQ?
SPE2DB25FQAJQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FQAJQ worth?
The government has obligated $3,459 on SPE2DB25FQAJQ.
Is contract SPE2DB25FQAJQ an order under another contract?
Yes. SPE2DB25FQAJQ is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAJQ competed?
The extent of competition for SPE2DB25FQAJQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award